In the complex landscape of pharmaceutical manufacturing, the quality of starting materials and intermediates dictates the efficacy and safety of the final drug product. One such critical intermediate, p-Anisaldehyde, known chemically as 4-Methoxybenzaldehyde (CAS No. 123-11-5), plays a pivotal role in the synthesis of Febuxostat. Febuxostat is a highly effective medication used globally for the treatment of hyperuricemia and chronic gout, conditions characterized by elevated uric acid levels in the blood.

The significance of p-anisaldehyde intermediate for Febuxostat synthesis cannot be overstated. Its precise molecular structure and high purity are essential to ensure the correct formation of Febuxostat, a xanthine oxidase inhibitor. Manufacturers rely on consistent access to this compound to meet the growing demand for gout treatments. Understanding the detailed 4-Methoxybenzaldehyde CAS 123-11-5 properties is therefore crucial for any pharmaceutical company involved in this synthesis chain.

With a purity specification of no less than 99.0%, p-Anisaldehyde guarantees that the downstream reactions proceed efficiently, minimizing unwanted by-products and maximizing the yield of the active pharmaceutical ingredient. This focus on quality is paramount, particularly when dealing with life-improving medications like Febuxostat. The compound's physical state as a colorless to light yellow liquid, with a density of 1.121 and a boiling point of 248-249°C, also makes it amenable to standard industrial processing techniques. Safety is also a key consideration, as evidenced by its flash point of 116°C, indicating it is manageable under controlled industrial conditions.

For companies looking to establish a robust supply chain for Febuxostat, securing a reliable source of high-quality p-anisaldehyde is a strategic imperative. The availability of this febuxostat precursor chemical synthesis in bulk quantities, typically packaged in 200 kg drums, ensures that production lines can operate without interruption. The demand for effective gout management solutions continues to grow, making the consistent availability of this intermediate a cornerstone of pharmaceutical supply.

Moreover, the scientific literature and industry reports often highlight the importance of understanding the nuanced p-anisaldehyde physical and chemical properties. These details are not just for academic interest; they are vital for process optimization, troubleshooting, and ensuring the overall success of the manufacturing process. By focusing on the critical intermediate, pharmaceutical companies can better manage production costs and ensure the delivery of high-quality Febuxostat to patients worldwide. The reliable sourcing of such intermediates is a testament to the rigorous standards upheld in the pharmaceutical chemical sector.

In essence, p-Anisaldehyde is more than just a chemical compound; it is a fundamental building block that enables the production of a vital medication, contributing significantly to public health by providing relief from the debilitating effects of gout and hyperuricemia. The meticulous attention to its properties and supply chain management underscores its importance in the modern pharmaceutical industry.